CU23031A1 - Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes - Google Patents

Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes

Info

Publication number: CU23031A1
Authority: CU; Cuba
Prior art keywords: mucosopt; immunopotentiator; hepatitis; virus; surface antigen
Prior art date: 2002-01-24

Application number

CU20020019A

Other languages

English (en)

Inventor

Mato Yadira Lobaina

Feyt Rolando Pajon

Zaldivar Regis Aleman

Gonzalez Verena Lucila Muzio

Rubido Julio Cesar Aguilar

Garcia Gretel Sardinas

Perez Enrique Iglesias

Nieto Gerardo Enrique Guillen

Noa Dioslaida Urquiza

Arias Eduardo Penton

Rando Eugenio Hardy

Obregon Julio Cesar Alvarez

Gonzalez Daymir Garcia

Original Assignee

Ct Ingenieria Genetica Biotech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-24

Filing date

2002-01-24

Publication date

2005-02-23

2002-01-24 Application filed by Ct Ingenieria Genetica Biotech filed Critical Ct Ingenieria Genetica Biotech

2002-01-24 Priority to CU20020019A priority Critical patent/CU23031A1/es

2003-01-22 Priority to CNA038026260A priority patent/CN1703241A/zh

2003-01-22 Priority to KR10-2004-7011504A priority patent/KR20040081469A/ko

2003-01-22 Priority to BRPI0307121-9A priority patent/BR0307121A/pt

2003-01-22 Priority to PCT/CU2003/000001 priority patent/WO2003061692A2/es

2003-01-22 Priority to CA002471727A priority patent/CA2471727A1/en

2003-01-22 Priority to EP03731653A priority patent/EP1493447A2/en

2003-01-22 Priority to US10/501,570 priority patent/US20050025780A1/en

2003-01-23 Priority to ARP030100201A priority patent/AR038311A1/es

2003-01-24 Priority to MYPI20030252A priority patent/MY141983A/en

2004-06-28 Priority to ZA200405140A priority patent/ZA200405140B/en

2005-02-23 Publication of CU23031A1 publication Critical patent/CU23031A1/es

Links

241000700721 Hepatitis B virus Species 0.000 title 1
239000000427 antigen Substances 0.000 title 1
102000036639 antigens Human genes 0.000 title 1
108091007433 antigens Proteins 0.000 title 1
230000000091 immunopotentiator Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Mycology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)

CU20020019A 2002-01-24 2002-01-24 Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes CU23031A1 (es)

Priority Applications (11)

Application Number	Priority Date	Filing Date	Title
CU20020019A CU23031A1 (es)	2002-01-24	2002-01-24	Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes
CNA038026260A CN1703241A (zh)	2002-01-24	2003-01-22	乙型肝炎病毒表面抗原作为粘膜免疫刺激物和得到的制剂
KR10-2004-7011504A KR20040081469A (ko)	2002-01-24	2003-01-22	점막 면역 자극제로서 간염 비 바이러스 표면 항원 및결과물로서의 제제
BRPI0307121-9A BR0307121A (pt)	2002-01-24	2003-01-22	antìgeno de superfìcie do vìrus da hepatite b como um imunoestimulador da mucosa e as formulações resultantes
PCT/CU2003/000001 WO2003061692A2 (es)	2002-01-24	2003-01-22	Antígeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes.
CA002471727A CA2471727A1 (en)	2002-01-24	2003-01-22	Hepatitis b virus surface antigen as a mucosal immunostimulator and the resulting formulations
EP03731653A EP1493447A2 (en)	2002-01-24	2003-01-22	Hepatitis b virus surface antigen as a mucosal immunostimulator and the resulting formulations
US10/501,570 US20050025780A1 (en)	2002-01-24	2003-01-22	Hepatitis b virus surface antigen as a mucosal immunostimulator and the resulting formulations
ARP030100201A AR038311A1 (es)	2002-01-24	2003-01-23	Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes
MYPI20030252A MY141983A (en)	2002-01-24	2003-01-24	Hepatitis b virus surface antigen as a mucosal immunoenhancer, resulting formulations
ZA200405140A ZA200405140B (en)	2002-01-24	2004-06-28	Hepatitus B virus surface antigen as a mucosal immunostimulator andthe resulting formulations

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CU20020019A CU23031A1 (es)	2002-01-24	2002-01-24	Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes

Publications (1)

Publication Number	Publication Date
CU23031A1 true CU23031A1 (es)	2005-02-23

Family

ID=27587819

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CU20020019A CU23031A1 (es)	2002-01-24	2002-01-24	Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes

Country Status (11)

Country	Link
US (1)	US20050025780A1 (es)
EP (1)	EP1493447A2 (es)
KR (1)	KR20040081469A (es)
CN (1)	CN1703241A (es)
AR (1)	AR038311A1 (es)
BR (1)	BR0307121A (es)
CA (1)	CA2471727A1 (es)
CU (1)	CU23031A1 (es)
MY (1)	MY141983A (es)
WO (1)	WO2003061692A2 (es)
ZA (1)	ZA200405140B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CU23405A1 (es) *	2003-10-20	2009-08-04	Ct Ingenieria Genetica Biotech	Composiciones farmacéuticas para uso terapéutico
GB0505518D0 (en) *	2005-03-17	2005-04-27	Chiron Srl	Combination vaccines with whole cell pertussis antigen
LT2351578T (lt) *	2005-06-27	2017-04-10	Glaxosmithkline Biologicals S.A.	Vakcinų gavimo būdas
CN104958759B (zh) *	2015-06-24	2018-04-27	康希诺生物股份公司	多价脑膜炎球菌制剂盒、疫苗制剂及其制备方法
RS65362B1 (sr)	2016-09-02	2024-04-30	Sanofi Pasteur Inc	Vakcina protiv neisseria meningitidis
AU2018313636B2 (en)	2017-08-10	2024-10-17	Yisheng Biopharma (Singapore) Pte Ltd	A composition for treating and/or preventing hepatitis B virus infection and the use thereof
BR112020005695A2 (pt) *	2017-10-05	2020-10-06	Toko Yakuhin Kogyo Co., Ltd.	composição da vacina da hepatite b nasal e método para produzir a mesma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4547368A (en) *	1983-12-20	1985-10-15	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Hepatitis B core antigen vaccine made by recombinant DNA
DE69319728T2 (de) *	1992-05-23	1999-02-04	Smithkline Beecham Biologicals S.A., Rixensart	Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten
US6153201A (en) *	1993-03-09	2000-11-28	University Of Rochester	Oral immunization with papillomavirus virus-like particles
GB9503863D0 (en) *	1995-02-25	1995-04-19	Smithkline Beecham Biolog	Vaccine compositions
CU22629A1 (es) *	1997-03-06	2000-12-22	Ct Ingenieria Genetica Biotech	Formulaciones inmunopotenciadoras para uso vacunal
CU22871A1 (es) *	1998-12-02	2003-10-21	Ct Ingenieria Genetica Biotech	Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal

2002
- 2002-01-24 CU CU20020019A patent/CU23031A1/es unknown
2003
- 2003-01-22 KR KR10-2004-7011504A patent/KR20040081469A/ko not_active Ceased
- 2003-01-22 WO PCT/CU2003/000001 patent/WO2003061692A2/es not_active Ceased
- 2003-01-22 CA CA002471727A patent/CA2471727A1/en not_active Abandoned
- 2003-01-22 CN CNA038026260A patent/CN1703241A/zh active Pending
- 2003-01-22 BR BRPI0307121-9A patent/BR0307121A/pt not_active IP Right Cessation
- 2003-01-22 EP EP03731653A patent/EP1493447A2/en not_active Withdrawn
- 2003-01-22 US US10/501,570 patent/US20050025780A1/en not_active Abandoned
- 2003-01-23 AR ARP030100201A patent/AR038311A1/es not_active Application Discontinuation
- 2003-01-24 MY MYPI20030252A patent/MY141983A/en unknown
2004
- 2004-06-28 ZA ZA200405140A patent/ZA200405140B/en unknown

Also Published As

Publication number	Publication date
EP1493447A2 (en)	2005-01-05
AR038311A1 (es)	2005-01-12
CA2471727A1 (en)	2003-07-31
WO2003061692A2 (es)	2003-07-31
ZA200405140B (en)	2006-07-26
BR0307121A (pt)	2006-04-11
MY141983A (en)	2010-08-16
US20050025780A1 (en)	2005-02-03
WO2003061692A3 (es)	2004-10-21
KR20040081469A (ko)	2004-09-21
CN1703241A (zh)	2005-11-30

Publication	Publication Date	Title
NL1022738A1 (nl)	2003-11-25	Stofzuiger.
NO2017005I1 (no)	2017-01-20	Human pappilomavirus vaksine [type 6, 11, 16, 18, 31, 33, 45, 52, 58]
IS8476A (is)	2006-05-18	Lifrarbólgu C-veirutálmar
IS8475A (is)	2006-05-18	Lifrarbólgu C-veirutálmar
DK1716162T3 (da)	2011-01-10	Phosphonater, amidomonophosphonater, amidobisphosphonater til behandling af virussygdomme
DE60139127D1 (de)	2009-08-13	Von hepatitis c virus
NO20021431D0 (no)	2002-03-21	Intranasal influensavirusvaksine
ATE427990T1 (de)	2009-04-15	Verbesserte reinigungsmethode fur viren
DE60334381D1 (de)	2010-11-11	Staubsauger
NO20030263D0 (no)	2003-01-20	Stövsuger
IS7830A (is)	2005-04-28	Bóluefni gegn lifrarbólgu C veiru (HCV)
AU2003206862A8 (en)	2003-09-02	Hepatitis b vaccines
ITMO20030012A0 (it)	2003-01-24	Aspirapolvere perfezionato.
EP1692279A4 (en)	2006-12-27	VIRUS PREPARATIONS CONTAINING A CONSERVATIVE
AU2003219057A8 (en)	2003-09-29	Recombinant drug-sensitive vaccinia virus as smallpox vaccine
ES2417019T8 (es)	2014-11-17	Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa
AU2003301850A8 (en)	2004-06-07	Hiv vaccine
AU2003294757A8 (en)	2004-06-23	Formulations useful against hepatitis c virus infections
DE60328408D1 (de)	2009-08-27	Impfstoff
ATE392903T1 (de)	2008-05-15	Impfstoff gegen pferdeherpesvirus
NO20024304D0 (no)	2002-09-09	Anordning ved stillbar stol
IS7775A (is)	2005-03-29	DNA bóluefni sem umritar að minnsta kosti tvö óformgerð árprótín af vörtuveiru
PL372453A1 (en)	2005-07-25	An infectious bursal disease virus variant
WO2006019841A3 (en)	2007-02-22	Treatment of viral infections with egr 1 activators
AU2003221569A8 (en)	2003-10-20	Cd4+ t-lymphocyte-specific hepatitis c virus epitopes